Clinical Trial Update: Effects of XW003 Versus Liraglutide on Body Weight of Adult Participants With Obesity [Phase 2]

View source ↗

Summary

Phase 2 trial comparing XW003 to liraglutide for body weight reduction in adults with obesity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• XW003
• liraglutide (liraglutide)

Snippet

Sponsor: Sciwind Biosciences APAC CO Pty. Ltd. | Conditions: Obesity | Phase 2 | Status: COMPLETED